DSCSA: Cell & gene compliance and patient safety

In this webinar regulatory experts Sanjay Padaki, Principal, Spark Consulting, LLC and Joe Lipari, Director of Product Management will discuss the critical aspects of compliance and patient safety in the rapidly advancing field of cell and gene therapies.

As the industry continues to innovate, ensuring patient safety while maintaining rigorous compliance standards has never been more essential. We will explore the systems, processes and technologies that are crucial to protecting patients throughout the lifecycle of cell and gene products, from development to delivery.

What you’ll get:

• Understand the difference between compliance regulations and the underlying patient safety needs in cell and gene therapies.
• A deep dive into the key systems and processes that ensure patient safety—such as tracking, traceability and robust testing protocols.
• Actionable steps to prepare for DSCSA compliance in a constantly evolving regulatory environment and how proactive measures can drive success.